EFHA1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.08849995683613E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.2002000000081E-05 |
Normal-vs-Stage2 |
3.400600E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.024290E-03 |
Stage1-vs-Stage2 |
5.078000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.206600E-04 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.218600E-03 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.91010000541547E-08 |
Normal-vs-AfricanAmerican |
3.145000E-01 |
Normal-vs-Asian |
8.130100E-02 |
Caucasian-vs-AfricanAmerican |
3.920200E-01 |
Caucasian-vs-Asian |
7.842800E-01 |
AfricanAmerican-vs-Asian |
4.306600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.424300E-04 |
Normal-vs-Female |
1.44629999998536E-06 |
Male-vs-Female |
8.561800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.817100E-03 |
Normal-vs-Extreme_Weight |
5.55139999999232E-05 |
Normal-vs-Obese |
7.560700E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.075200E-01 |
Normal_Weight-vs-Obese |
1.122450E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.842960E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.635800E-01 |
Normal-vs-Age(41-60Yrs) |
5.766900E-04 |
Normal-vs-Age(61-80Yrs) |
1.86105999999686E-05 |
Normal-vs-Age(81-100Yrs) |
1.208200E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.702600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.076200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.100800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.081200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.458200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.746600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.068400E-01 |
Normal-vs-Grade 3 |
7.752300E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.864000E-01 |
Grade 2-vs-Grade 4 |
5.068400E-01 |
Grade 3-vs-Grade 4 |
7.752300E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.15250000046296E-07 |
Normal-vs-N1 |
6.102200E-03 |
N0-vs-N1 |
9.65569999999971E-05 |
|
|